Abstract
Background and aims: The prevalence of prediabetes is increasing in Jordan and the Middle East region, which is leading to increased risk of type 2 diabetes and micro- and macro-complications. The aims of the expert panel were to understand and evaluate the current prediabetes situation and practice in Jordan and make recommendations to standardize the management of patients with prediabetes in Jordan. Methods: A panel of diabetes experts met to discuss and review all the current literature related to the region and international guidelines on prediabetes. The panel evaluated and developed a comprehensive understanding, addressing the definition, screening, diagnosis, pharmacological treatment, and management of prediabetes with consideration of local factors. Results: The experts relied on international data to establish criteria with cut-off values for screening and diagnosis to identify asymptomatic patients with prediabetes and diabetes. The panel made protocol recommendations, including lifestyle modifications, and developed potential treatment algorithms to provide guidance on the overall management for Jordanian prediabetic patients. Conclusion: The panel of experts reached consensus recommendations with a tailored detection, screening, and treatment algorithm in anticipation for a country wide adoption and implementation. These recommendations would help increase awareness of prediabetes in Jordan and create local guidelines to better serve Jordanian physicians in the management of patients with prediabetes.
Highlights
The number of adults with IGT (2019 estimates) is 374 million with almost half of them below 50 years old; this is due to the high prevalence of obesity in this age group [1, 2]
A literature review of the existing data on prediabetes, professional opinions and experience discussion between 10 diabetes experts resulted in a consensus on screening, detection, diagnosis and management of prediabetes in Jordan
The panel agreed that due to lack of local studies, Jordanian physicians should rely on international guidelines for cut-off values, mainly the ADA for prediabetes diagnosis
Summary
The number of adults with IGT (2019 estimates) is 374 million with almost half of them below 50 years old; this is due to the high prevalence of obesity in this age group [1, 2]. IFG international) met on the 24th of September 2018 to understand or IGT or raised glycated hemoglobin >5.5% (AACE), >5.7% & evaluate the status of prediabetes diagnosis and treatment in (ADA) to
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Diabetes and Endocrinology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
